3D Printing in Bioengineering and Pharmaceutical Manufacturing
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Pharmaceutical Technology, Manufacturing and Devices".
Deadline for manuscript submissions: 20 March 2026 | Viewed by 83
Special Issue Editor
Interests: bioengineering; tissue engineering; regenerative medicine; 3D-printing; 3D-bioprinting; musculoskeletal science
Special Issue Information
Dear Colleagues,
3D printing is rapidly transforming bioengineering and pharmaceutical manufacturing by enabling complex geometries, on-demand production, and true personalization. This Special Issue examines advances in bioprinting tissues and organs, 3D-printed drug delivery systems, and hybrid manufacturing workflows that integrate materials science, microfluidics, and process analytics to realize precision therapeutics. Emphasis is placed on patient-specific formulations—controlled-release, implantable scaffolds, and dosing devices—designed from patient data and enabled by CAD-to-print pipelines and regulatory-aware quality control. The challenges covered include biomaterial biocompatibility and stability, scale-up and reproducibility, supply-chain integration, and regulatory and ethical frameworks for personalized products. The emerging directions highlighted include AI-enabled (e.g., machine-learning-driven) design optimization, multi-material and cell-laden printing, closed-loop manufacturing with real-time monitoring, and decentralized production models for point-of-care therapy. Collectively, the collected papers aim to map the technical milestones and translational pathways required to move 3D-printed bioactive constructs from lab innovation to safe, regulated clinical and manufacturing practice and implementation.
Dr. Darren J. Player
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- 3D printing
- 3D-bioprinting
- precision medicine
- personalized medicine
- bioengineering
- pharmaceutical manufacturing
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
